Stephan Weber1, Keiji Kamohara, Ryan S Klatte
1The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. webers2@ccf.org
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The MagScrew Total Artificial Heart (TAH) system shows promising results in early testing. This innovative device demonstrated excellent performance and biocompatibility in vivo, suggesting potential for future heart failure treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: